Aethlon Medical Inc. has three reporting persons – Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC – who report beneficial ownership of its common stock through a warrant position. As of the close of business on June 30, 2026, they may be deemed to beneficially own 55,556 shares of common stock issuable upon exercise of a warrant held by Intracoastal (the “Intracoastal Warrant”). This stake represents approximately 2.3% of Aethlon Medical’s common stock.
The percentage is based on 2,370,560 shares of common stock outstanding as of June 8, 2026, plus the 55,556 warrant shares. All 55,556 shares are reported with shared voting and dispositive power, and no shares are held with sole voting or dispositive power. The reporting group indicates ownership of 5 percent or less of the class.
Positive
None.
Negative
None.
Key Figures
Beneficially owned shares:55,556 sharesOwnership percentage:2.3%Shares outstanding baseline:2,370,560 shares+2 more
5 metrics
Beneficially owned shares55,556 sharesShares of common stock issuable upon exercise of the Intracoastal Warrant as of June 30, 2026
Ownership percentage2.3%Approximate percentage of Aethlon Medical common stock beneficially owned through the warrant position
Shares outstanding baseline2,370,560 sharesCommon stock outstanding as of June 8, 2026, used to calculate ownership percentage
Shared voting power55,556 sharesShares over which the reporting persons have shared power to vote or direct the vote
Shared dispositive power55,556 sharesShares over which the reporting persons have shared power to dispose or direct disposition
"each of the Reporting Persons may have been deemed to have beneficial ownership of 55,556 shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting powerfinancial
"Shared Voting Power 55,556.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerfinancial
"Shared Dispositive Power 55,556.00"
warrantfinancial
"shares of Common Stock issuable upon exercise of a warrant held by Intracoastal"
A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.
percent of classfinancial
"Percent of class: 2.3%"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
FAQ
What percentage of Aethlon Medical (AEMD) does Intracoastal Capital and its affiliates report owning?
They report beneficial ownership of approximately 2.3% of Aethlon Medical’s common stock. This is based on 2,370,560 shares outstanding as of June 8, 2026, plus 55,556 shares issuable upon exercise of the Intracoastal Warrant.
How many Aethlon Medical (AEMD) shares are tied to the Intracoastal Warrant?
The Intracoastal Warrant is exercisable into 55,556 shares of Aethlon Medical common stock. These warrant shares form the entire reported beneficial position and are treated as outstanding solely for calculating the reporting persons’ ownership percentage.
Who are the reporting persons in this Aethlon Medical (AEMD) Schedule 13G/A?
The reporting persons are Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. Kopin and Asher are U.S. individuals, while Intracoastal is a Delaware limited liability company holding the warrant position.
What voting and dispositive powers do the reporting persons have over Aethlon Medical (AEMD) shares?
They report 0 shares with sole voting or dispositive power and 55,556 shares with shared voting and shared dispositive power. This indicates decisions over these warrant shares are made jointly among the reporting persons.
How was the 2.3% ownership in Aethlon Medical (AEMD) calculated?
The 2.3% figure uses a base of 2,370,560 common shares outstanding as of June 8, 2026, plus 55,556 shares issuable upon exercise of the Intracoastal Warrant, with only those warrant shares added to the outstanding count.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
AETHLON MEDICAL INC
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
00808Y703
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
00808Y703
1
Names of Reporting Persons
Mitchell P. Kopin
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
55,556.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
55,556.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
55,556.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.3 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
CUSIP Number(s):
00808Y703
1
Names of Reporting Persons
Daniel B. Asher
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
55,556.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
55,556.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
55,556.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.3 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
CUSIP Number(s):
00808Y703
1
Names of Reporting Persons
Intracoastal Capital LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
55,556.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
55,556.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
55,556.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.3 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
AETHLON MEDICAL INC
(b)
Address of issuer's principal executive offices:
11555 Sorrento Valley Road, Suite 203, San Diego, California 92121
Item 2.
(a)
Name of person filing:
This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
(b)
Address or principal business office or, if none, residence:
The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
(c)
Citizenship:
Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
(d)
Title of class of securities:
Common Stock, par value $0.001 per share
(e)
CUSIP No.:
00808Y703
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of the close of business on June 30, 2026, each of the Reporting Persons may have been deemed to have beneficial ownership of 55,556 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal (the "Intracoastal Warrant"), and all such shares of Common Stock represent beneficial ownership of approximately 2.3% of the Common Stock, based on (1) 2,370,560 shares of Common Stock outstanding as of June 8, 2026, as reported by the Issuer, plus (2) 55,556 shares of Common Stock issuable upon exercise of the Intracoastal Warrant.
(b)
Percent of class:
2.3%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
55,556
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
55,556
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.